{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:14:22Z","timestamp":1772118862736,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI106701"],"award-info":[{"award-number":["UM1 AI106701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["AI068632"],"award-info":[{"award-number":["AI068632"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["UM1 AI068636"],"award-info":[{"award-number":["UM1 AI068636"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["K24AI150349"],"award-info":[{"award-number":["K24AI150349"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R01HD074944"],"award-info":[{"award-number":["R01HD074944"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["UM1 AI068634"],"award-info":[{"award-number":["UM1 AI068634"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jpba.2024.116613","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T12:00:50Z","timestamp":1733313650000},"page":"116613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous analysis of isoniazid and pyrazinamide in cerebrospinal fluid"],"prefix":"10.1016","volume":"255","author":[{"given":"Sydwell Poulo","family":"Maputla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Castel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marthinus","family":"van der Merwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edda","family":"Zangenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly E.","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116613_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/JLB.MR0318-102R","article-title":"The pathogenesis of tuberculous meningitis","volume":"105","author":"Davis","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jpba.2024.116613_bib2","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.3390\/jcm9092962","article-title":"Analysis of tuberculosis meningitis pathogenesis, diagnosis, and treatment","volume":"9","author":"Arshad","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpba.2024.116613_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000069","article-title":"The global burden of tuberculous meningitis in adults: a modelling study","volume":"1","author":"Dodd","year":"2021","journal-title":"PLOS Glob. Public Health"},{"key":"10.1016\/j.jpba.2024.116613_bib4","series-title":"Tubercular Drug Delivery Systems: Advances in Treatment of Infectious Diseases","first-page":"59","article-title":"Tuberculosis: current treatment options and future scope","author":"Shah","year":"2023"},{"key":"10.1016\/j.jpba.2024.116613_bib5","series-title":"WHO Consolidated Guidelines on Tuberculosis. Module 5: Management of Tuberculosis in Children and Adolescents","author":"W.H. Organization","year":"2022"},{"key":"10.1016\/j.jpba.2024.116613_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0966-842X(98)01216-5","article-title":"Mechanisms of latency in Mycobacterium tuberculosis","volume":"6","author":"Parrish","year":"1998","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jpba.2024.116613_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/10408347.2017.1281098","article-title":"Isoniazid: a review of characteristics, properties and analytical methods","volume":"47","author":"Fernandes","year":"2017","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116613_bib8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1365-2958.2000.02145.x","article-title":"3rd, Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis","volume":"38","author":"Slayden","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jpba.2024.116613_bib9","series-title":"Treatment of Tuberculosis: Guidelines","author":"Organization","year":"2010"},{"key":"10.1016\/j.jpba.2024.116613_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.1957.02980090001001","article-title":"Impact of isoniazid on tuberculous meningitis","volume":"164","author":"Weiss","year":"1957","journal-title":"J. Am. Med Assoc."},{"key":"10.1016\/j.jpba.2024.116613_bib11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/cpt.1783","article-title":"Pharmacokinetics and pharmacodynamics of intensive antituberculosis treatment of tuberculous meningitis","volume":"107","author":"Ding","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2024.116613_bib12","unstructured":"W. Shi, X. Zhang, X. Jiang, H. Yuan, J.S. Lee, C.E. Barry, H. Wang, W. Zhang, Y. Zhang, Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis, (n.d.). https:\/\/doi.org\/10.1126\/science.1160753."},{"key":"10.1016\/j.jpba.2024.116613_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cpt.180","article-title":"Optimizing the clinical pharmacology of tuberculosis medications","volume":"98","author":"Egelund","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2024.116613_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1542\/peds.89.2.247","article-title":"Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: the influence of dosage and acetylation status","volume":"89","author":"Donald","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpba.2024.116613_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00006454-198807000-00003","article-title":"Cerebrospinal fluid pyrazinamide concentrations in children with tuberculous meningitis","volume":"7","author":"Donald","year":"1988","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.jpba.2024.116613_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tube.2010.07.002","article-title":"Cerebrospinal fluid concentrations of antituberculosis agents in adults and children","volume":"90","author":"Donald","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jpba.2024.116613_bib18","unstructured":"U.S. FDA, Bioanalytical method validation guidance for industry, US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research and Center for Veterinary Medicine (2018)."},{"key":"10.1016\/j.jpba.2024.116613_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","article-title":"Standard line slopes as a measure of a relative matrix effect in quantitative HPLC\u2013MS bioanalysis","volume":"830","author":"Matuszewski","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116613_bib20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/cid\/ciac932","article-title":"A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus-associated tuberculous meningitis: the LASER-TBM trial","volume":"76","author":"Davis","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2024.116613_bib21","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/cid\/ciac208","article-title":"Randomized clinical trial of high-dose rifampicin with or without levofloxacin versus standard of care for pediatric tuberculous meningitis: the TBM-KIDS trial","volume":"75","author":"Paradkar","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2024.116613_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1350699","article-title":"Pyrazinoic acid, the active form of the anti-tuberculosis drug pyrazinamide, and aromatic carboxylic acid analogs are protonophores","volume":"11","author":"Fontes","year":"2024","journal-title":"Front Mol. Biosci."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:21:12Z","timestamp":1769689272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524006551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":21,"alternative-id":["S0731708524006551"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116613","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous analysis of isoniazid and pyrazinamide in cerebrospinal fluid","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116613"}}